Article Information
History
- August 25, 2020.
Article Versions
- Version 1 (August 21, 2020 - 08:12).
- Version 2 (August 23, 2020 - 08:06).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Fabian Rudolf1,+,*,
- Hans-Michael Kaltenbach1,+,
- Janina Linnik1,
- Marie-Therèse Ruf2,3,
- Christoph Niederhauser4,5,
- Beatrice Nickel2,3,
- Daniel Gygax6 and
- Miodrag Savic3,7,8
- 1D-BSSE ETH Zürich & Swiss Institute of Bioinformatics, Basel, Switzerland
- 2Swiss Tropical and Public Health Institute, Basel, Switzerland
- 3University of Basel, Basel, Switzerland
- 4Interregional Blood Transfusion SRC, Bern, Switzerland
- 5Institute for Infectious Diseases, University of Bern, Bern, Switzerland
- 6University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
- 7University Hospital of Basel, Basel, Switzerland
- 8Department of Health, Economics and Health Directorate Canton Basel-Landschaft, Liestal, Switzerland
- ↵*correspondence should be addressed to fabian.rudolf{at}bsse.ethz.ch
↵+ these authors contributed equally
Posted August 25, 2020.
Clinical Characterisation of Eleven Lateral Flow Assays for Detection of COVID-19 Antibodies in a Population
